Study of Camizestrant for Patients with ER+/HER2- Early Breast Cancer After 2 Years of Standard Endocrine Therapy
- Substances:AnastrozoleCamizestrant+6
Czechia- Participants:18–64 years · 65+ years
- Substances:Anastrozole
- Sponsor:AstraZeneca AB
Rare diseases
Investigational molecules
Locations
Back to Czechia160 clinical trials in Pardubice, Czechia. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in CzechiaKlinickeTesty.cz(opens in a new tab)
CzechiaA Phase 2b Study Evaluating the Efficacy and Safety of ENV-294 in Adults with Moderate-to-Severe Atopic Dermatitis
CzechiaStudy of zenagamtide versus insulin glargine in adults with type 2 diabetes and high cardiovascular risk uncontrolled on oral medications
CzechiaKAI-9531 in Adults With Obesity or Overweight and Diabetes
CzechiaA study to evaluate the effect of muvalaplin on reducing major cardiovascular events in adults with high levels of lipoprotein(a) and atherosclerotic cardiovascular disease.
CzechiaStudy of IMG-007 injection to treat moderate to severe atopic dermatitis in adults
CzechiaStudy on the Effects of PPV-06 and Paracetamol for Patients with Inflammatory Knee Osteoarthritis
CzechiaStudy on the Effectiveness and Safety of ANB032, Hydrocortisone, and Alclometasone Dipropionate for Patients with Moderate to Severe Atopic Dermatitis
CzechiaStudy on the Effectiveness and Safety of Tocilizumab and Methotrexate for Adults with Moderate to Severe Rheumatoid Arthritis
CzechiaStudy of the safety and effectiveness of TRIV-573 injections in adults with moderate to severe atopic dermatitis
CzechiaStudy of oral STL303 hydrochloride to assess safety and effectiveness in adults with geographic atrophy secondary to age‑related macular degeneration
CzechiaSafety and Efficacy of Two Doses of OCUL101 Compared with Aflibercept in Patients with Neovascular Age‑Related Macular Degeneration
CzechiaThe busiest research cities in the country
What the registry says about research in the country
Clinical trials focusing on vaccine development for preventable diseases, including studies of new chickenpox vaccines and advanced meningococcal vaccines for infants and children.
Research emphasizes immune response monitoring and safety assessment in young populations.
Innovative research targeting various autoimmune disorders, with studies evaluating new treatments for psoriatic arthritis and multiple sclerosis.
Trials focus on developing targeted therapies for chronic inflammatory conditions.
Studies investigating new therapeutic approaches for Parkinson's Disease and other neurological conditions, with emphasis on improving patient outcomes.
Research aims to enhance treatment options and quality of life for patients.
Advanced clinical trials focusing on prostate cancer treatment, particularly addressing metastatic castration-resistant cases.
Studies emphasize novel therapeutic approaches for advanced-stage cancers.
Research investigating treatments for osteoarthritis and joint disorders, including innovative therapies for knee-specific conditions.
Focus on developing both systemic and topical treatments for joint diseases.
Tell us about your condition – we search every trial in Europe and connect you with the right site.